Viking Therapeutics Inc (VKTX)

[ZeWaffleBaron]

They would be to add extra data collection or testing within their target population (hip fracture), that could further explore that area of interest. They have chosen their patient population well imho, and seems like the quickest way to market because of the high mortality rate. The process of getting drugs approved for additional indications is quite complex and requires a lot of FDA involvement. Their big endpoints were short term musculoskeletal stuff, looking into long term bone stuff, or at least suggesting it might be helpful, is a new direction of sorts, and them bringing it up now at KOL is very very interesting.